LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
3.000
0.00 (0.00%)
Mar 6, 2026, 4:00 PM EST - Market closed
LifeMD Revenue
LifeMD had revenue of $60.17M in the quarter ending September 30, 2025, with 12.95% growth. This brings the company's revenue in the last twelve months to $250.09M, up 28.78% year-over-year. In the year 2024, LifeMD had annual revenue of $212.45M with 39.27% growth.
Revenue (ttm)
$250.09M
Revenue Growth
+28.78%
P/S Ratio
0.58
Revenue / Employee
$814,631
Employees
307
Market Cap
144.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 212.45M | 59.91M | 39.27% |
| Dec 31, 2023 | 152.55M | 33.51M | 28.15% |
| Dec 31, 2022 | 119.03M | 26.16M | 28.16% |
| Dec 31, 2021 | 92.88M | 55.58M | 149.04% |
| Dec 31, 2020 | 37.29M | 24.83M | 199.10% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Claritev | 965.41M |
| TruBridge | 347.27M |
| Health Catalyst | 316.06M |
| American Well | 249.33M |
| Definitive Healthcare | 241.52M |
| So-Young International | 201.13M |
| Spok Holdings | 139.71M |
| CareCloud | 114.32M |
LFMD News
- 4 days ago - LifeMD to Participate in Two Investor Conferences During March - GlobeNewsWire
- 9 days ago - LifeMD: Still My Favorite Bargain On The Market - Seeking Alpha
- 12 days ago - LifeMD to Report Fourth Quarter 2025 Financial Results on March 9 - GlobeNewsWire
- 4 weeks ago - LifeMD: Pure Telehealth Play With In-House Pharmacy Integration - Seeking Alpha
- 2 months ago - LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A. - GlobeNewsWire
- 2 months ago - LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill - GlobeNewsWire
- 2 months ago - LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - GlobeNewsWire
- 3 months ago - LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME's America's Growth Leaders of 2026 - GlobeNewsWire